Felix Stader
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Evaluating alterations in drug-metabolizing enzymes in cancer: insights from in vivo, in vitro, and biomarker studies.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 22, 2025
Correction: Cross-species translational modelling of targeted therapeutic oligonucleotides using physiologically based pharmacokinetics.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: July 30, 2025
PBPK Modelling of Antisense Oligonucleotide Therapeutics: Application for Predicting Plasma and Tissue Pharmacokinetics of Bepirovirsen.
Journal: The AAPS journal
Published: July 08, 2025
Investigating Sulfotransferase Mediated Drug Interactions of Ethinylestradiol using a Physiologically Based Pharmacokinetic Model.
Journal: The AAPS journal
Published: June 27, 2025
Modeling and Simulation Identifies Endocytosis Uptake Rate and Fraction Unbound as Important Predictors of Oligonucleotide Pharmacokinetics.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 23, 2025
Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study.
Journal: Pharmaceutics
Published: May 31, 2025
The physiological limits of bispecific monoclonal antibody tissue targeting specificity.
Journal: mAbs
Published: April 14, 2025
Accelerating Biologics PBPK Modelling with Automated Model Building: A Tutorial.
Journal: Pharmaceutics
Published: March 29, 2025
Physiologically Based Pharmacokinetic Modeling of Biologic Case Studies in Monkeys and Humans Reveals the Necessity of an Additional Clearance Term.
Journal: Pharmaceutics
Published: March 09, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric Patients.
Journal: The AAPS journal
Published: February 23, 2025
Cross-species translational modelling of targeted therapeutic oligonucleotides using physiologically based pharmacokinetics.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: January 29, 2025
Applications of the Cholesterol Metabolite, 4β-Hydroxycholesterol, as a Sensitive Endogenous Biomarker for Hepatic CYP3A Activity Evaluated within a PBPK Framework.
Journal: Pharmaceutics
Published: July 23, 2024
Last Updated: 09/26/2026